Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Reviews

The management of post-transplantation recurrence of hepatocellular carcinoma

Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin

Clin Mol Hepatol. 2022;28(1):1-16. Published online October 5, 2021

Web of Science 37 Crossref 41

DOI: https://doi.org/10.3350/cmh.2021.0217

Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus

Sun Woong Kim, Jun Sik Yoon, Minjong Lee, Yuri Cho

Clin Mol Hepatol. 2022;28(1):17-30. Published online July 20, 2021

Web of Science 38 Crossref 37

DOI: https://doi.org/10.3350/cmh.2021.0093

Current knowledge about biomarkers of acute kidney injury in liver cirrhosis

Han Ah Lee, Yeon Seok Seo

Clin Mol Hepatol. 2022;28(1):31-46. Published online August 2, 2021

Web of Science 14 Crossref 15

DOI: https://doi.org/10.3350/cmh.2021.0148

Editorials

Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?

Seung Mi Lee, Won Kim

Clin Mol Hepatol. 2022;28(1):47-49. Published online November 30, 2021

Web of Science 4 Crossref 4

DOI: https://doi.org/10.3350/cmh.2021.0338

Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment

Ja-Young Kwon

Clin Mol Hepatol. 2022;28(1):50-51. Published online November 22, 2021

DOI: https://doi.org/10.3350/cmh.2021.0359

Original Articles

Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes

Hydar El Jamaly, Guy D Eslick, Martin Weltman

Clin Mol Hepatol. 2022;28(1):52-66. Published online September 17, 2021

Web of Science 14 Crossref 17

DOI: https://doi.org/10.3350/cmh.2021.0205

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Hyung-Don Kim, Seon-Ok Kim, Ha Il Kim, Gi-Won Song, Han Chu Lee, Ju Hyun Shim

Clin Mol Hepatol. 2022;28(1):67-76. Published online October 12, 2021

Web of Science 2 Crossref 2

DOI: https://doi.org/10.3350/cmh.2021.0202

U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases

Huapeng Lin, Grace Lai-Hung Wong, Xinrong Zhang, Terry Cheuk-Fung Yip, Ken Liu, Yee Kit Tse, Vicki Wing-Ki Hui, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2022;28(1):77-90. Published online November 5, 2021

Web of Science 18 Crossref 17

DOI: https://doi.org/10.3350/cmh.2021.0188

A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective

Hye-Lin Kim, Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook-Hyang Jeong

Clin Mol Hepatol. 2022;28(1):91-104. Published online November 5, 2021

Web of Science 16 Crossref 15

DOI: https://doi.org/10.3350/cmh.2021.0236

Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods

Seung Mi Lee, Suhyun Hwangbo, Errol R. Norwitz, Ja Nam Koo, Ig Hwan Oh, Eun Saem Choi, Young Mi Jung, Sun Min Kim, Byoung Jae Kim, Sang Youn Kim, Gyoung Min Kim, Won Kim, Sae Kyung Joo, Sue Shin, Chan-Wook Park, Taesung Park, Joong Shin Park

Clin Mol Hepatol. 2022;28(1):105-116. Published online October 15, 2021

Web of Science 8 Crossref 9

DOI: https://doi.org/10.3350/cmh.2021.0174

Snapshot

Current status and outcome of liver transplantation in South Korea

Ho Joong Choi

Clin Mol Hepatol. 2022;28(1):117-119. Published online December 7, 2021

Web of Science 12 Crossref 12

DOI: https://doi.org/10.3350/cmh.2021.0381

Viewed By 5341	MAFLD: How is it different from NAFLD?
Viewed By 5103	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4671	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4655	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4497	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 253	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 204	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 139	MAFLD: How is it different from NAFLD?
Cited By 114	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Previous issues